Eisai
4523.T
#2489
Rank
โ‚น705.20 B
Marketcap
โ‚น2,500
Share price
-2.03%
Change (1 day)
8.11%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น82.89. an increase over its 2024 EPS that were of โ‚น93.44.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น104.5211.85%
2024โ‚น93.44-32.63%
2023โ‚น138.715.52%
2022โ‚น131.45-74.01%
2021โ‚น505.71-66.58%
2020โ‚น1,51398.24%
2019โ‚น763.2017.01%
2018โ‚น652.2437.78%
2017โ‚น473.41-27.62%
2016โ‚น654.0735.33%
2015โ‚น483.32-2.82%
2014โ‚น497.36-27.66%
2013โ‚น687.57-27.49%
2012โ‚น948.28-12.67%
2011โ‚น1,08688.08%
2010โ‚น577.36-11.06%
2009โ‚น649.18-390.15%
2008-โ‚น223.74-127.78%
2007โ‚น805.5111.78%
2006โ‚น720.644.38%
2005โ‚น690.437.4%
2004โ‚น642.8843.03%
2003โ‚น449.4925.09%
2002โ‚น359.3252.67%
2001โ‚น235.3569.76%
2000โ‚น138.64